News Release

Georgetown researcher: 2 or more drinks a day may increase pancreatic cancer risk

Peer-Reviewed Publication

Georgetown University Medical Center

Washington, DC -- Men and women who consume two or more alcoholic drinks a day could increase their risk of developing pancreatic cancer, according to a study published in Cancer Epidemiology, Biomarkers and Prevention, a journal of the American Association for Cancer Research.

Previous studies have been unable to confirm the association between drinking and the risk of pancreatic cancer, but most studies depended on a person's recall of alcohol intake. Still, many hypothesize about the relationship between alcohol and pancreatic cancer because drinking is associated with the risk of pancreatitis and diabetes, and both of these conditions are known risk factors for developing the disease.

Unlike the previous studies, this current research pools data collected prospectively from 14 research studies, which included 862,664 individuals (319,716 men and 542,948 women). Data collected prospectively means information about dietary and environmental exposures were collected prior to diagnosis with pancreatic cancer. Researchers identified 2,187 individuals diagnosed with pancreatic cancer during the study.

"This is one of the largest studies ever to look at dietary factors in relation to pancreatic cancer risk," says lead author Jeanine M. Genkinger, Ph.D., an assistant professor at Georgetown University's Lombardi Comprehensive Cancer Center.

If individuals consumed 30 or more grams of alcohol per day (approximately two drinks), compared with no alcohol per day, their risk of pancreatic cancer was slightly increased, researchers said. A drink is defined as 12 ounces of beer, four ounces of wine, or 1.5 ounces of 80-proof distilled liquor.

Although, there was no statistically significant difference between men and women when comparing alcohol intake with risk of pancreatic cancer, the association was seen in women at two or more drinks per day. Comparatively, the researchers observed a higher risk among men who consumed three or more drinks a day.

No difference was observed by type of alcohol when comparing beer, distilled liquor or wine, according to Genkinger.

"Despite being a deadly disease, there are few known risk factors for developing pancreatic cancer," explains Genkinger. "At this point, it's important to understand any protective or risk factors for this dangerous disease even if the risks are weak or modest."

###

In addition to chronic pancreatitis and diabetes, smoking is considered the strongest risk factor for pancreatic cancer. According to the American Cancer Society, there were approximately 18,910 new cases of pancreatic cancer reported in 2008 and 34,290 deaths.

The study was funded by a grant from the National Cancer Institute. The authors report no potential financial conflicts.

About Lombardi Comprehensive Cancer Center

The Lombardi Comprehensive Cancer Center, part of Georgetown University Medical Center and Georgetown University Hospital, seeks to improve the diagnosis, treatment, and prevention of cancer through innovative basic and clinical research, patient care, community education and outreach, and the training of cancer specialists of the future. Lombardi is one of only 41 comprehensive cancer centers in the nation, as designated by the National Cancer Institute, and the only one in the Washington, DC, area. For more information, go to http://lombardi.georgetown.edu.

About Georgetown University Medical Center

Georgetown University Medical Center is an internationally recognized academic medical center with a three-part mission of research, teaching and patient care (through our partnership with MedStar Health). Our mission is carried out with a strong emphasis on public service and a dedication to the Catholic, Jesuit principle of cura personalis -- or "care of the whole person." The Medical Center includes the School of Medicine and the School of Nursing and Health Studies, both nationally ranked, the world-renowned Lombardi Comprehensive Cancer Center and the Biomedical Graduate Research Organization (BGRO), home to 60 percent of the university's sponsored research funding.


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.